Recombinant plasmid PEGFP-12 obtained by mutating mycobacterium tuberculosis ERP 12 sequence motif to PGLTS
A technology of PEGFP-12 and Mycobacterium tuberculosis, applied in the field of bioengineering, can solve the problems of unknown molecular mechanism, the relationship between conservation and function has not been studied, and achieve the effect of obvious inflammatory response
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0012] The technical solution of the present invention will be further described in detail below in conjunction with the accompanying drawings and specific embodiments.
[0013] The complete sequence of ERP with 12 motifs completely mutated into PGLTS was synthesized by KingScript Biotechnology Co., Ltd., humanized and optimized, and constructed on the PEGFP-N1 eukaryotic expression vector. The cloning site is HindIII / PstI, and Named PEGFP-12. The mutated sequence is shown as SEQ:ID:NO:1.
[0014] Transform the vector into Escherichia coli to extract the plasmid, transfer the plasmid into A549 cells by lipofection, and then do protein chip detection to see the changes of cytokines after transfection compared with wild type, for research PGLTS motif mutations and functional relationships provide robust data.
[0015] PEGFP-12 and PEGFP-ERP recombinant plasmids were transfected into A549 cells as follows: figure 1 , figure 2 shown. The recombinant plasmid was transformed i...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com